Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Methylphenidate on Motor Performance in ADHD
NCT04283604Phase 4Recruiting
- Sponsor
- Loewenstein Rehabilitation Hospital
- Start
- May 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Loewenstein Rehabilitation Hospital. Started May 2021; status: recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT04283604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04283604.